PML

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA008312

Antibody CAB010194

Antibody CAB016304

Tissue

Antibody staining

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

Weak to moderate nuclear and/or cytoplasmic staining was observed in most malignancies. Several urothelial and renal cancers showed strong nuclear staining. A fraction of cases in most malignancies showed weak to moderate nuclear immunoreactivity. Remaining malignant cases were negative.Malignant cells generally exhibited nuclear staining of moderate to strong intensity. Most cases of testicular, breast and liver cancer were negative.

Literature conformity

Consistent with extensive gene/protein characterization dataConsistent with extensive gene/protein characterization dataConsistent with extensive gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected